Latest filing published 10 Oct 2025 for China Health Group Ltd., €10k. Read the official filing
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wang Jingming appears in our data through filings on China Health Group Ltd. shares, published by HKEX. The record holds 10 filings, for trades running from 24 January 2018 to 6 October 2025.
On the market, this insider has only ever bought: 10 purchases, €214k in total. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €13k. On 6 out of 9 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 9 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 44% of cases, with a median move of -4.3%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 10 October 2025, reports an open-market purchase of €10k in China Health Group Ltd. Between a trade and the moment it shows up on HKEX, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations